When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

The findings highlight the importance of rheumatology, cardiology, and primary care working together to intervene early.

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

The multidisciplinary care required to treat these complex patients is most often found in higher-volume centers.

With its twice-yearly dosing, the siRNA-based drug might lead to better compliance with treatment. Still, cost is an issue.

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).

Individuals assigned male at birth who were pushed to change their identity had more inflammation and higher blood pressure.

It’s not as “perfect as they are selling it,” but it does avoid the more catastrophic complications of thermal ablation, says ...

Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care ...

By group, procedural success and freedom from LVOT obstruction (LVOT mean gradient > 50 mm Hg), the primary efficacy endpoint ...